Stay updated on PHA-022121 Dose Study for Acute Angioedema Clinical Trial

Sign up to get notified when there's something new on the PHA-022121 Dose Study for Acute Angioedema Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PHA-022121 Dose Study for Acute Angioedema Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov site revision label changed from v3.7.2 to v3.8.0.
    Difference
    0.1%
    Check dated 2026-11-01T13:10:09.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    A notice was added explaining that NIH websites are transitioning terminology from “Artificial Intelligence” to “Super Intelligence,” with links to updates and FAQs.
    Difference
    0.4%
    Check dated 2026-10-25T13:09:48.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The site footer revision label changed from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-18T14:09:17.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov site revision identifier changed from v3.7.0 to v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-11T13:32:48.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    The study history now includes a new revision entry (v3.7.0) indicating an updated submission. The previous revision (v3.6.6) has been removed from the current history view.
    Difference
    0.1%
    Check dated 2026-09-20T11:19:46.000Z thumbnail image
  6. Check
    66 days ago
    Change Detected
    Summary
    The latest entry in the study's history adds Revision: v3.6.6 and removes Revision: v3.6.5, reflecting a minor update to the page's revision tracking. This indicates a small backend or metadata update on the history page.
    Difference
    0.1%
    Check dated 2026-08-29T23:49:09.000Z thumbnail image

Stay in the know with updates to PHA-022121 Dose Study for Acute Angioedema Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PHA-022121 Dose Study for Acute Angioedema Clinical Trial page.